drugset / Trial / NCT01613482
TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the survival without metastasis in patients treated by Trastuzumab in association with other chemotherapies for a breast cancer expressing HER2-NEU.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-08
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Trastuzumab | Monoclonal antibody | 2 mg/kg | — |